fashion -WSS

fashion

author：knowledge 2025-09-28 04:13:02 - browse：5

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Crowdfunding for unproven stem cell procedures spreads misinformation

knowledge

WSS

ACA's risk program benefits Blue Cross Blue Shield insurers

What affirmative action's end means to a medical student

The wait for US passports is creating travel purgatory and snarling summer plans

Prescription digital therapeutics are key to pharma’s future

A letter from the executive editor: The 2023 STATUS List

Lupron, used to halt puberty in children, may cause lasting health problems

Wikipedia

fashion

leisure time

In age of alternative facts, a scholarly course on calling out crap

UpToDate has a racism problem: Dr. Stanley Goldfarb

Medicare proposal to cover medical devices draws a mixed reaction

Canadians with cystic fibrosis outlive Americans by a decade

Medicare details structure of new drug price negotiation program

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Prescription digital therapeutics are key to pharma’s future

Psychedelics group wrestles with new pharma identity

Prescription digital therapeutics are key to pharma’s future

hotspot

Undocumented workers face uncertainty as immigration law takes effect in Florida

Fatty liver disease was alleviated by Lilly’s ‘triple

Eisai exec who led development of Alzheimer’s drug to retire

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Home health providers sue Medicare over payment cuts

Swim instructor mom warns parents not to buy blue swimsuits for kids

explore

knowledge

focus

hotspot